However, prophylactic or therapeutic administration of rCV02 prevented the significant decrease of dynamin 1 (Fig. 8A,B) and PSD-95 (Fig. 8C,D) in aged 3 × Tg-AD mice. This evidence concerns the gene DNM1 and Alzheimer disease.